CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...

INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click ...

Biogen and Eisai said the European Medicines Agency's Committee for Medicinal Products for Human Use has reaffirmed its recommended approval of their Alzheimer's drug Leqembi. The companies on ...

Eisai and Biogen's Alzheimer's therapy Leqembi will be priced at $26,500 per year – a little less than misfired predecessor Aduhelm – after getting conditional authorisation for the drug from ...

Leqembi (lecanemab-irmb) is a brand-name drug prescribed to treat Alzheimer’s disease in adults with mild cognitive impairment or mild dementia. The drug comes as an intravenous (IV) infusion ...

NPR's Jon Hamilton has been talking to people who've taken these drugs, and today he has the story of one of the first patients to receive the drug now marketed as Leqembi. JON HAMILTON ...

Eisai has filed to extend the label for its Alzheimer’s disease therapy Leqembi to include a maintenance dosing regimen that would reduce the number of intravenous infusions needed to one per month.

So, what’s really going on? In early 2023, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new Alzheimer’s drug called Leqembi. (Biogen, a biotechnology company ...

It might become a family affair in East Lansing. On Thursday, On3 reported that four-star athlete Salesi Moa set an early official visit with Michigan State for the weekend of April 2. Moa's ...

In 1934, the NZ Herald reported on moa remains discovered in a swamp on a Canterbury farm. Photo / Mark Mitchell Kem Ormond takes a look at the world of farming back in the day. Moa were large ...

Good morning everyone, it’s Jason Mast, filling in for Ed. Today I’m in Pharmalittle’s New York bureau, sipping a cup poured from a French press gifted to me by my sisters, made from beans ...

Vials of Eisai and Biogen's new Alzheimer's drug Leqembi 34,796 people played the daily Crossword recently. Can you solve it faster than others?34,796 people played the daily Crossword recently.